Theorem Clinical Research

Global News

PCORI approves $102M in support of 46 new research projects

Wednesday, October 1, 2014 01:23 PM

The Patient-Centered Outcomes Research Institute (PCORI), a Wash. D.C.-based independent nonprofit organization, has approved 46 new proposals, totaling nearly $102 million in support, to fund a wide range of patient-centered clinical comparative effectiveness research (CER) projects.

More... »


NIH awards initial $46 million for BRAIN Initiative research

Wednesday, October 1, 2014 01:21 PM

The NIH has announced its first wave of investments totaling $46 million in fiscal year 2014 to support the goals of the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative. More than 100 investigators in 15 states and several countries will work to develop new tools and technologies to understand neural circuit function and capture a dynamic view of the brain in action.

More... »


Report: Biosimilars to revolutionize global drug development, 700 therapies in pipelines

Wednesday, October 1, 2014 01:20 PM

There currently are 700 follow-on biologics therapies moving through pipelines, with many already approved, and 245 biopharma companies and institutes developing or already marketing follow-on biologics in markets throughout the world, according to Thomson Reuters.

More... »

Horizon Discovery Group acquires Sage Labs for $48M

Wednesday, October 1, 2014 01:18 PM

Horizon Discovery Group, a Cambridge, U.K.-based international life science company supplying research tools and services to organizations engaged in genomics research and the development of personalized medicines, has agreed to acquire Sage Labs, a St. Louis, Mo.-based provider of advanced in vivo transgenic disease models for use in preclinical research, for up to $16 million in cash and up to $32 million through the issue of new ordinary shares.

More... »

WuXi PharmaTech acquires XenoBiotic Laboratories

Wednesday, October 1, 2014 01:11 PM

CRO WuXi PharmaTech, with operations in China and the U.S., has acquired XenoBiotic Laboratories (XBL), a CRO with facilities in New Jersey and China. Financial terms have not been disclosed.

More... »

Consort Medical to acquire Aesica Pharmaceuticals for $373 million

Wednesday, October 1, 2014 01:08 PM

Consort Medical is acquiring Aesica Pharmaceuticals for $373 million. The closing of the transaction, expected to occur in November, is conditional on the approval of Consort Medical’s shareholders and clearance by the German competition authorities.

More... »

Pfizer, Kyowa Hakko Kirin collaborate on immuno-oncology combination study

Wednesday, October 1, 2014 01:07 PM

Pfizer and Tokyo-based Kyowa Hakko Kirin have entered into an agreement to explore the therapeutic potential of the combination of Pfizer’s PF-05082566, an investigational, fully humanized monoclonal antibody (mAb) that stimulates signaling through 4-1BB (CD-137), a protein involved in regulation of immune cell activation, proliferation and survival, with Kyowa Hakko Kirin’s anti-CCR4 antibody mogamulizumab, which suppresses some of the immune cells that shield the tumor from the immune system, in a phase Ib clinical study evaluating the safety and tolerability of the combination in patients with solid tumors.

More... »

Johnson & Johnson to acquire Alios BioPharma

Wednesday, October 1, 2014 01:04 PM

Johnson & Johnson has announced a definitive agreement to acquire Alios BioPharma, a San Francisco-based, privately held clinical stage biopharmaceutical company focused on developing therapies for viral diseases, for approximately $1.75 billion in cash.

More... »

The CenterWatch Monthly, October 2014

Wednesday, October 1, 2014 06:00 AM

CROs driving changes in patient recruitment

More... »

Lumara Health to be acquired in two separate transactions

Monday, September 29, 2014 01:26 PM

Lumara Health, a Missouri-based specialty pharmaceutical company, has entered into two separate definitive agreements for the sale of its maternal health business and, separately, the sale of its women's healthcare assets.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

October 20

Toronto Star, with FDA data, exposes weaknesses in Health Canada's clinical trial, inspection oversight

Crowdsourcing effort aims to fund updated online social media guide for sponsor interaction with patients

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

September

Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs